The research group in hematology is devoted to clinical and translational trials in hematology, focused on diagnosis, prognosis and the development of new therapies to treat hematological malignancies such as leukemias and myelomas. 


The group uses a variety of approaches such as genetic studies of the immune response, pharmacogenomics in response to treatment, analysis of polymorphisms as disease predictors and the study of cell populations using flow cytometry for the characterization of residual disease.

Through our research, we aim to:

  • Investigate biological, clinical, and epidemiological aspects of hematological diseases.
  • Carry out translational research projects focused on finding prognostic factors or treatment response predictors.
  • Carry out clinical research, promoting participation in clinical trials for hematological diseases and participating in national and international cooperative groups.


David GallardoGroup Leader
Anna Angona FiguerasAttending Physician
Gemma Osca GelisPostdoctoral Investigator
Yolanda González MontesPhD Student
Johana Alejandra Diaz SantaPhD Student
Nazly Santos CarvajalPhD Student
David Cruz GarcíaPhD Student
Josep Maria Ronccero VidalAssociate Investigator
Esperanza Tuset AndújarAssociate Investigator
Rosa Coll JordàAssociate Investigator
Natalia Lloveras GuelqueAssociate Investigator
Nichollas John KelleherAssociate Investigator
Antonio Blanco BlancoAssociate Investigator
Anna Bustins TarratsAssociate Investigator
Silvia Zdenka Mostacedo MarasovicAssociate Investigator
Marta Sitges ArriagaAssociate Investigator
Jordi Vila BouAssociate Investigator
Rocío Rodríguez RomanosTechnician
Marta González BártulosTechnician